Comparative Antitumor Activity of 5-Fluorouracil and 5’-Deoxy-5-Fluorouridine in Combination with Interferon-α in Renal Cell Carcinoma Cell Lines

Publisher： Karger

E-ISSN： 1423-0399|73|4|348-353

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.73, Iss.4, 2004-12, pp. : 348-353

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Outcome of Combined Interferon-α and 5-Fluorouracil Treatment for Advanced Hepatocellular Carcinoma with Major Portal Vein Thrombosis

By  

Oncology, Vol. 80, Iss. 1-2, 2011-06 ,pp. : 63-69

Karger

Access to resources Recommend Favorite

Prediction of Response to 5′-Deoxy- 5-Fluorouridine (5′-DFUR) in Patients with Inoperable Advanced Gastric Cancer by Immunostaining of Thymidine Phosphorylase/Platelet-Derived Endothelial Cell Growth Factor

By  

Oncology, Vol. 56, Iss. 3, 1999-04 ,pp. : 215-222

Karger

Access to resources Recommend Favorite

A Phase II Study with 5-Fluorouracil, Folinic Acid and Oxaliplatin (FOLFOX-4 Regimen) in Patients with Metastatic Renal Cell Carcinoma

By  

Oncology, Vol. 64, Iss. 1, 2002-12 ,pp. : 25-27

Karger

Access to resources Recommend Favorite

Clinical resolution of vemurafenib‐induced squamous cell carcinoma with topical 5‐fluorouracil

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 4, 2015-04 ,pp. : 1135-1136

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intra‐arterial 5‐fluorouracil/interferon combination therapy for hepatocellular carcinoma with portal vein tumor thrombosis and extrahepatic metastases

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 25, Iss. 6, 2010-06 ,pp. : 1117-1122

John Wiley & Sons Inc

Access to resources Recommend Favorite